Responding to dynamic shifts in value communicationsOPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means Share XResponding to dynamic shifts in value communicationshttps://deep-dive.pharmaphorum.com/magazine/communications-2020/responding-to-dynamic-shifts-in-value-communications/
Deep Dive: Communications 2020COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve Share XDeep Dive: Communications 2020https://pharmaphorum.com/sales-marketing/deep-dive-communications-2020/
Commercialising innovative new medicinesAs pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination Share XCommercialising innovative new medicineshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/commercialising-innovative-new-medicines/
Helping HCPs navigate the ever-evolving advanced cancer landscapeOPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can Share XHelping HCPs navigate the ever-evolving advanced cancer landscapehttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/helping-hcps-navigate-the-ever-evolving-advanced-cancer-landscape/
Breaking barriers to patient access in rare oncologyAs technological advances unlock a more nuanced understanding of disease – and exciting opportunities for personalised medicine – Share XBreaking barriers to patient access in rare oncologyhttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/breaking-barriers-to-patient-access-in-rare-oncology/
Jeff Anderson joins OPEN Health in European lead roleJeff Anderson has joined OPEN Health as European Lead for its OPEN VIE and Pharmerit Europe practices. In Share XJeff Anderson joins OPEN Health in European lead rolehttps://pharmaphorum.com/news/open-health-jeff-anderson-vie-pharmerit/
Delivering change through better rare disease communicationsOPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders Share XDelivering change through better rare disease communicationshttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/delivering-change-through-better-rare-disease-communications/
OPEN Health launches new Learning & Development specialist teamOPEN Health has launched a new specialist Learning & Development (L&D) team that will further expand its existing Share XOPEN Health launches new Learning & Development specialist teamhttps://pharmaphorum.com/sales-marketing/open-health-launches-new-learning-development-specialist-team/
Open Health merges with HEOR and market access firm PharmeritOpen Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move Share XOpen Health merges with HEOR and market access firm Pharmerithttps://pharmaphorum.com/news/open-health-merger-heor-pharmerit/
